UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
306.00
-4.61 (-1.48%)
At close: Feb 26, 2026
UCB SA Market Cap
UCB SA has a market cap or net worth of $56.75 billion as of February 27, 2026. Its market cap has increased by 59.69% in one year.
Market Cap
56.75B
Enterprise Value
56.61B
Revenue
9.09B
Ranking
n/a
PE Ratio
31.02
Stock Price
$306.00
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 56.75B, an increase of 4,626.61%. That is a compound annual growth rate of 13.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 56.64B | 6.42% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 361.16M |
| CytoDyn | 320.26M |
| Silence Therapeutics | 256.95M |
| Vaxart | 190.78M |
| BioStem Technologies | 94.76M |
| Nuo Therapeutics | 72.43M |
| HST Global | 70.56M |
| Vicapsys Life Sciences | 48.56M |